BioSpace News Archive

Astellas Pharma US, Inc. announced the call for entries for the Astellas Oncology C3 Prize, a global challenge that funds the best non-treatment ideas to improve cancer care for patients, caregivers and their loved ones.

Heska Corporation, a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments for its second quarter ended June 30, 2020.

HUYA Bioscience International (HUYABIO ® ), the leader in accelerating global development of China’s pharmaceutical innovations, announced today it has exclusively licensed worldwide rights, outside of China , to the SHP2 inhibitor, HBI-2376, from Suzhou GenHouse. SHP2 is an import

Bolsters Team in Key Areas of Business Strategy and Clinical Development

Collaboration intended to support Phase 3 development and commercialization of PH94B for anxiety-related disorders in key Asian markets

ReViral Ltd., a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics that target respiratory syncytial virus, announced that the U.S. Food and Drug Administration has granted Fast Track designation to sisunatovir for the treatment of patients with serious RSV infection.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference. Todd Bazemore, Chief Operating Officer of Kala Pharmaceuticals, is scheduled to present on Tuesday, August 11, 2020 at 1:10 p.m. ET. To access a

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that senior management will be presenting and hosting 1x1 meetings at the following virtual investor conferences in August: BTIG Virtual Biotechnology Conference 2020 Presentation Date: Tuesday, August 11, 2020 Time: 11:30 a.m. ET 2020 Wedbush PacGrow Healthcare Virtual Conference Presentation Date: Wednesday, August 12, 20

Emergent Health Corp. purpose of this Press Release is to further update our shareholders on the Company’s overall business.

Nascent Biotech, Inc, a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat cancers and viral infections, has participated in the recent expert panel discussion entitled “BCG: a therapeutic modality for COVID-19 and cancers” hosted by the Bioidea Group.